Media Coverage

Advanced Search
  • 05172022
    American Journal of Managed Care

    By predicting which individuals are most likely to require therapies for chronic kidney disease within the next year, health plans can better organize resource allocation to smooth or delay the transition for the patient, according to Rehan Waheed, MD of Quest Diagnostics.

  • 05172022
    EHS Today

    The rate of positive drug test results among America’s workforce in 2021 reached its highest level since 2001 and was up more than 30% in the combined workforce from an all-time low in 2010-2012, Quest Diagnostics’ annual Drug Testing Index found. Although year-over-year comparisons showed only small increases in 2021 over 2020, Quest said it rose substantially over the previous five years in most drug categories.

  • 05132022

    A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.

  • 05122022
    Healthcare Business Today

    "2022 Health at Work" report from Quest Diagnostics reveals the attitudes and expectations of HR executive decision makers (HREs) and employees about the changing world of work, employee health and COVID-19, and what it takes to compete for today's scarcest resource–people.

  • 05112022
    Becker's Hospital Review

    A majority of physicians believe medicine is on the verge of groundbreaking new treatments for Alzheimer's disease, according to research from Quest Diagnostics.

  • 05112022

    While value-based care contracts have long played a role in the lab industry, recent comments by Quest Diagnostics executives suggest that such arrangements are growing more prominent and more profitable.

  • 05102022
    BenefitsPRO Magazine

    As millions of U.S. employees voluntarily resign and employers desperately scramble to find workers, a new survey suggests employee health strategy might be critical not only to keeping employees well but also keeping them at work. The “2022 Health at Work” report, released by Quest Diagnostics, addresses such hot-button topics as the changing world of work, employee health, and COVID-19.

  • 05092022
    The Pathologist

    Digital pathology is here to stay – and we need to embrace it. About the Author: Martin Potash is Managing Director of AmeriPath Denver, Quest Diagnostics, Colorado, USA.

  • 05042022
    MedCity News

    Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early detection typically relies on costly methods such as brain imaging and cerebrospinal fluid taps. Blood tests like the one developed by Quest promise to make detection easier, less costly and more accessible.

  • 04292022

    Testicular cancer is highly treatable when diagnosed before reaching advanced stages, and like most cancers, early detection is key in helping to combat it. It’s recommended that males perform routine self-testicular exams, especially between the ages of 18 and 40, and pay close attention to any new findings such as changes of size of the testicle, differences with new firm areas or bumps that have not been there before. "Whether you’re regularly going to the doctor’s office or not, anyone with testicles should administer an at-home check every month or so,” said Dr. Jeffrey Dlott, the medical director of QuestDirect.